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Abstract
Background: Extravasation and luminal entry of plasma occurs continuously in the nose. This
process is markedly facilitated in patients with symptomatic allergic rhinitis, resulting in an
increased secretion of proteins. Identification of these proteins is an important step in the
understanding of the pathological mechanisms in allergic diseases. DNA microarrays have recently
made it possible to compare mRNA profiles of lavage fluids from healthy and diseased patients,
whereas information on the protein level is still lacking.
Methods: Nasal lavage fluid was collected from 11 patients with symptomatic allergic rhinitis and
11 healthy volunteers. 2-dimensional gel electrophoresis was used to separate proteins in the
lavage fluids. Protein spots were picked from the gels and identified using mass spectrometry and
database search. Selected proteins were confirmed with western blot.
Results:  61 spots were identified, of which 21 were separate proteins. 6 of these proteins
(psoriasin, galectin-3, alpha enolase, intersectin-2, Wnt-2B and hypothetical protein MGC33648)
had not previously been described in nasal lavage fluids. The levels of psoriasin were markedly
down-regulated in allergic individuals. Prolactin-inducible protein was also found to be down-
regulated, whereas different fragments of albumin together with Ig gamma 2 chain c region,
transthyretin and splice isoform 1 of Wnt-2B were up-regulated among the allergic patients.
Conclusion:  The identification of proteins in nasal lavage fluid with 2-dimensional
gelelectrophoresis in combination with mass spectrometry is a novel tool to profile protein
expression in allergic rhinitis and it might prove useful in the hunt for new therapeutic targets or
diagnostic markers for allergic diseases. Psoriasin is a potent chemotactic factor and its down-
regulation during inflammation might be of importance for the outcome of the disease.
Background
Increased vascular permeability and plasma exudation are
important characteristics of allergic rhinitis leading to an
increased amount of secreted proteins [1,2]. Earlier inves-
tigations with DNA microarray analysis [3] have described
the gene expression in nasal mucosa. However, there is a
considerable interest to identify some of the secreted pro-
teins for a better understanding of the pathological
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processes and possibly to find new therapeutical targets or
diagnostic markers for the disease.
Combining 2-dimensional gel electrophoresis (2-DE)
with mass spectrometry (MS) have recently emerged as a
method for identifying proteins in different biological
samples. In short, proteins are separated in the first
dimension according to their isoelectric points (pI) and
then in the second dimension according to their molecu-
lar weight using SDS-PAGE. Each spot on the SDS-PAGE
gel corresponds to one protein. The spots can be excised
and further analysed and identified using mass spectrom-
etry and database searching [4]. 2-DE together with MS
has previously been used to investigate the protein con-
tent in nasal lavage fluid (NLF) [5] and a study of differ-
ences in the NLF protein content from smokers and non-
smokers [6] is recently reported. However, changes in rela-
tion to allergic airway diseases have so far not been
probed. The main purpose of this study was to use 2-DE
in combination with MS and database search in order to
map and identify the broad range of secreted proteins in
NLF from individuals allergic to pollen (birch/timothy)
and to compare that with NLF from non-allergic healthy
individuals.
Materials and methods
Skin prick test
Skin prick tests (SPT) were performed with a standard
panel of 10 common airborne allergens (ALK, Copenha-
gen, Denmark) including pollen (birch, timothy and
artemisia), house dust mites (D. Pteronyssimus and D. Fari-
nae), molds (Cladosporium  and  Alternaria) and animal
allergens (cat, dog and horse). SPT were performed on the
volar side of the forearm with saline buffer as negative and
histamine chloride (10 mg/ml) as positive controls. The
diameter of the wheal reactions were measured after 20
min with a ruler.
Subjects
The study included 11 patients (6 women) with sympto-
matic birch and/or grass pollen induced intermittent aller-
gic rhinitis and 11 healthy volunteers (7 women), serving
as controls. The mean age of patients and controls was 43
(26–55) and 41 (24–55) years, respectively. The diagnosis
of birch and/or grass pollen induced allergic rhinitis was
based on a positive history of intermittent allergic rhinitis
for at least 2 years and positive SPT to birch and/or grass.
All patients were classified as having severe symptoms
(itchy nose and eyes, sneezing, nasal secretion and nasal
blockage) during pollen season and they had all been
treated with antihistamines and nasal steroids during pol-
len seasons previous years. Patients had no continuous
symptoms of asthma and they did not take any asthma
medication. All patients presented a wheal reaction diam-
eter >3 mm towards birch or timothy in SPT (roughly cor-
reponding to a 3+ or 4+ reaction when compared with
histamine [7]). Exclusion criteria included a history of
perennial symptoms, upper airway infection for the last 2
weeks before the time of visit and treatment with local or
systemic corticosteroids during the last 2 months. The
controls were all symptom-free, had no history of allergic
rhinitis and had negative SPT to the standard panel of
allergens as described above. They had no history of upper
airway infection for 2 weeks before the time of visit and
they were all free of medication. The study was approved
by the Ethics Committee of the Medical Faculty, Lund
University.
Sample collection and preparation
Nasal lavage fluid was collected during either birch pollen
(9 patients) or grass pollen season (2 patients). Patients
were included when they had experienced substantial
symptoms of rhinoconjunctivitis (itchy nose and eyes,
sneezing, nasal secretion and nasal blockage) during at
least 3 consecutive days. The majority of the patients were
seen within 5–10 days after the first appearance of symp-
toms and a local pollen count.
Nasal lavage fluid was collected according to a previously
described method [8]. After clearing of excess mucus from
the nose sterile saline solution of room temperature was
sprayed into both nostrils, respectively. The fluid was
allowed to return passively and collected in a graded tube
until 7 ml was recovered. NLFs were centrifuged at 1750
rpm at 4°C for 10 min to remove the cell content and the
supernatants were stored at -70°C until sample
preparation.
Before concentration of the samples NLFs were thawed
and centrifuged at 12300 rpm at 4°C for 20 min to
remove debris. Using Vivaspin 6 and Vivaspin 500 con-
centrators (Vivascience, Hannover, Germany) superna-
tants were concentrated and desalted. The protein
concentration was determined using BCA Protein Assay
Kit (Pierce Biotechnology, Rockford, USA) and resulted in
a protein concentration of 1572–5625 µg/ml for healthy
individuals and 1833–7867 µg/ml for allergic individuals.
NLFs were stored at -70°C until analysed.
2-DE analysis
Samples were mixed with rehydration solution containing
8 M Urea, 2% CHAPS, 2.8 mg/ml DTT (Sigma-Aldrich,
Steinheim, Germany), 0.5% IPG Buffer (pH 3–10) (Amer-
sham Biosciences, Uppsala Sweden) and a small amount
of bromophenol blue. For analytical gels 150 µg of pro-
tein was added to a final volume of 450 µl for each sam-
ple. For the preparative gels, one for healthy and one for
allergic samples, 600 µg from a pool of samples was used.
To be able to load as much as 600 µg on the preparative
gels pooled samples were further concentrated usingRespiratory Research 2005, 6:118 http://respiratory-research.com/content/6/1/118
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Microcon YM-3 (Millipore, Billerica, USA) before added
to rehydration solution. Samples were incubated for
approximately 15 min in room temperature in order to
completely solubilize and denature the proteins. Samples
were centrifuged at 13000 rpm for 10 min and thereafter
loaded onto 24 cm 3–10 non linear IPG strips (Amersham
Biosciences, Uppsala, Sweden). In-gel rehydration and
isoelectric focusing (IEF) was performed over night
(~60000 Vh) using Ettan IPGphor Isoelectric Focusing
System (Amersham Biosciences, Uppsala, Sweden). After
IEF strips were stored at -70°C until analysed. The IPG
strips were equilibrated in SDS equilibration buffer (75
mM Tris, 6 M Urea, 30% glycerol, 2% SDS and 0.002%
bromophenol blue (Sigma-Aldrich, Steinheim, Ger-
many)) for 2 × 15 min. DTT (10 mg/ml) (Sigma-Aldrich,
Steinheim, Germany) was added to the first and iodoa-
cetamide (25 mg/ml) (Sigma- Aldrich, Steinheim, Ger-
many) to the second equilibration step. After
equilibration strips were loaded onto laboratory-made
12.5% acrylamide second dimension gels. SDS-PAGE was
performed at constant effect (10 W/gel) for about 4 h and
30 min using the Ettan DALT II system (Amersham
Biosciences).
Staining of gels and gel image analysis
Second dimension gels were fixed in 30% ethanol and
10% acetic acid over night, washed 4 × 30 min in 20% eth-
anol and stained with the fluorescent dye ruthenium II
tris-bathophenantroline disulfonate (1 µM) for about 6 h.
Thereafter gels were destained in 40% ethanol and 10%
acetic acid over night and washed with double distilled
water for about 4 × 30–60 min [9]. All incubation and
washing steps were performed with gentle agitation. Gels
were kept dark in double distilled water at 4°C until
scanned. The gels were automatically scanned using a
robotic system together with a 9410 Typhoon scanner
(488 nm laser) from Amersham Biosciences [10] and the
gel images were analysed using the computer softwares
Image master 2D Platinum (Amersham Biosciences) and
Ludesi 2D Interpreter (Ludesi AB, Lund, Sweden). The
volume in each spot was calculated as integrated optical
density over the spot's area. The amount of protein in each
spot was expressed as %VOL (ppm), that is the volume for
the spot divided with the total volume for all spots in the
gel.
Spot picking, protein digestion and MALDI-TOF (Matrix 
Assisted Laser Desorption Ionization-Time Of Flight) 
analysis
Using the Ettan spot handling workstation (Amersham
Biosciences) selected spots were automatically cut from
the preparative gels, destained and enzymatically digested
with trypsin (porcine Sequencing Grade Modified
Trypsin, Promega, Madison, USA). The tryptic peptides
were then spotted onto a MALDI target plate [11]. The
MALDI target plates were loaded in a Micromass M@ldi
MALDI-TOF mass spectrometer (Waters, Milford, USA)
for analysis of the peptide masses.
Database search
Peptide masses retrieved from MALDI-TOF analysis spec-
tra were submitted to a database (IPI human 1.38) [12] by
using the search engine PIUMS [13]. The following
matcher parameters were used: constant modification of
cysteine by carbamidomethylation, variable modification
of methionine by oxidation and maximum 1 missed
cleavage for trypsin. A protein hit was considered signifi-
cant if the PIUMS quality score was ≥ 4.7, which corre-
sponds to an expectation value of 0.01. A search in IPI
human 1.38 was also done using the search engine Mascot
and the results from this search were compared with the
results from PIUMS.
Western blot
NLFs were mixed with SDS sample buffer, heated at 95–
100°C for 5 min and centrifuged at 10 000 rpm for 10
min. Equal amounts of the samples were loaded onto
NuPAGE Bis-Tris 4–12% gel (Invitrogen, Carlsbad, USA),
separated by electrophoresis (Mini vertical gel system,
Thermo EC, Waltham, USA), and blotted to Immobilon-
P PVDF membranes (Millipore, Billerica, USA). Mem-
branes were blocked in buffer 1 (Tris-HCl 10 mM pH 7.4,
NaCl 0.9% and dry milk 5%) and then incubated over-
night with primary antibody (1 µg/ml) against psoriasin,
galectin-3 (Abcam, Cambridge, UK), Wnt-2B (Zymed,
South San Francisco, USA) and alpha enolase (Santa Cruz,
Santa Cruz, USA), respectively. Membranes were washed
2 times with buffer 1 followed by incubation for approxi-
mately 2 h with HRP conjugated secondary antibody (50
ng/ml). After 2 washes with buffer 2 (Tris-HCl 10 mM pH
7.4, NaCl 0.9% and Tween 20 0.05%) membranes were
incubated for 5 min in SuperSignal West Pico solution
(Pierce Biotechnology, Rockford, USA). The chemilumi-
nescence was detected using MAN-X X-ray system (Fuji-
film Science Imaging systems, USA). Developed films for
quantitative analysis were scanned and analysed in Image-
Quant (Molecular dynamics, Sunnyvale, USA). There
were no antibodies available against hypothetical protein
MGC33648 and the relevant fragment of intersectin-2.
Hence, these proteins could not be assessed with western
blot.             
Statistical analysis
All values were expressed as mean values ± SEM. Statistical
analysis of the protein expression was performed in
Ludesi 2D interpreter (Ludesi AB) using one-way ANOVA.Respiratory Research 2005, 6:118 http://respiratory-research.com/content/6/1/118
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Results
Novel proteins in nasal lavage fluid
Of the spots picked from the 2D-gels and submitted to
MALDI-TOF analysis 61 spots were identified (figure 1
and table 1). 21 of these were identified as separate pro-
teins. The majority of the proteins has previously been
identified in NLF [5,6,14] but this is the first study where
psoriasin, galectin-3, alpha enolase, intersectin-2, Wnt-2B
and hypothetical protein MGC33648 have been recog-
nized. The occurrence of psoriasin, galectin-3, Wnt-2B
and alpha enolase was confirmed with western blot (fig-
ure 2).
Differences in protein expression between allergic and 
non-allergic individuals
14 spots exhibited a clear difference in the protein content
when the material from allergic and non-allergic individ-
uals was compared (table 2). 8 of these spots were identi-
fied as different fragments of albumin and all these were
up-regulated in allergic individuals (1.8- to 2.6-fold).
Wnt-2B (splice isoform 1), transthyretin and Ig gamma-2
chain c region were also found to be up-regulated in aller-
gic compared to non-allergic individuals (2.5-, 1.6- and
2.1-fold, respectively). In contrast, prolactin-inducible
protein and two forms of psoriasin were found to be
down-regulated in allergic individuals (2.0-, 2.0- and 3.4-
fold, respectively). The psoriasin levels in nasal lavage flu-
ids from three patients with allergic rhinitis and three con-
trols were also assessed using western blot analysis (figure
3A). Quantitative analysis revealed reduced levels among
the allergic patients; 19962 ± 5410 for the non-allergic
individuals compared to 6834 ± 2258 for the allergic indi-
viduals (figure 3B).
2-DE protein pattern for NLF from a healthy non-allergic individual Figure 1
2-DE protein pattern for NLF from a healthy non-allergic individual. The protein name for each numbered spot is presented in 
table 1.Respiratory Research 2005, 6:118 http://respiratory-research.com/content/6/1/118
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Table 1: Identified proteins in nasal lavage fluid from allergic and non-allergic individuals.
Gel no. Protein Accession no. 
(Swissprot/IPI)
MW (kDa) (theoretical) pI (theoretical)
1 Albumin P02768 69.4 5.9
2 Albumin P02768 69.4 5.9
3 Albumin P02768 69.4 5.9
4 Albumin P02768 69.4 5.9
5 Albumin P02768 69.4 5.9
6 Albumin P02768 69.4 5.9
7 Albumin P02768 69.4 5.9
8 Albumin P02768 69.4 5.9
9 Albumin P02768 69.4 5.9
10 Albumin P02768 69.4 5.9
11 Albumin P02768 69.4 5.9
12 Albumin P02768 69.4 5.9
13 Albumin P02768 69.4 5.9
14 Albumin P02768 69.4 5.9
15 Albumin P02768 69.4 5.9
16 Albumin P02768 69.4 5.9
17 Albumin P02768 69.4 5.9
18 Albumin IPI00216773 45.2 6.0
19 Albumin IPI00384697 47.4 6.3
20 Albumin IPI00384697 47.4 6.3
21 Albumin IPI00384697 47.4 6.3
22 Albumin IPI00384697 47.4 6.3
23 Albumin IPI00384697 47.4 6.3
24 Albumin IPI00384697 47.4 6.3
25 Albumin IPI00384697 47.4 6.3
26 Albumin IPI00384697 47.4 6.3
27 Prolactin-inducible protein P12273 16.6 8.3
28 Prolactin-inducible protein P12273 16.6 8.3
29 Prolactin-inducible protein P12273 16.6 8.3
30 Prolactin-inducible protein P12273 16.6 8.3
31 Cystatin S P01036 16.2 4.9
32 Cystatin S P01036 16.2 4.9
33 Cystatin SN P01037 18.8 6.8
34 Hemoglobin beta chain P68871 16.0 7.3
35 Hemoglobin beta chain P68871 16.0 7.3
36 Intersectin 2,
(splice isoform 2)
Q9NZM3-2 190.5 8.4
37 Lipocalin-1 P31025 19.3 5.4
38 Transthyretin P02766 15.9 5.5
39 Calgranulin B P06702 13.2 5.7
40 Psoriasin (S100A7) P31151 11.5 6.3
41 Psoriasin (S100A7) P31151 11.5 6.3
42 Galectin-3 P17931 26.2 8.6
43 Apolipoprotein A1 P02647 30.8 5.5
44 Apolipoprotein A1 P02647 30.8 5.5
45 Apolipoprotein A1 P02647 30.8 5.5
46 Alpha-2 glycoprotein 1, 
zink
P25311 34.3 5.9
47 Alpha-2 glycoprotein 1, 
zink
P25311 34.3 5.9
48 Serotransferrin P02787 77.1 6.8
49 Serotransferrin P02787 77.1 6.8
50 Serotransferrin P02787 77.1 6.8
51 Serotransferrin P02787 77.1 6.8
52 Alpha enolase P06733 47.0 7.0
53 Alpha enolase P06733 47.0 7.0Respiratory Research 2005, 6:118 http://respiratory-research.com/content/6/1/118
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Discussion
The present study is the first where 2-DE in combination
with MS has been used to study differences between aller-
gic and non-allergic individuals. It reveals the presence of
six novel NLF proteins: psoriasin, galectin-3, alpha eno-
lase, intersectin-2, Wnt-2B and hypothetical protein
MGC33648. One of these novel proteins, psoriasin, was
markedly down-regulated in allergic individuals. The
same was found for prolactin-inducible protein, whereas
different fragments of albumin together with Ig gamma 2
chain c region, transthyretin and splice isoform 1 of Wnt-
2B were up-regulated among the allergic patients.
Increased vascular permeability and plasma exudation are
important characteristics of allergic rhinitis resulting in an
increased secretion of proteins. Several of the secreted pro-
teins are collected in NLF and their identification is of
importance for understanding pathological mechanisms
in allergic rhinitis. DNA microarray technology is a rela-
tively new method for analysing gene expression in differ-
ent samples and it has recently been used in allergy
research [15,16]. With DNA microarray technology it is
possible to map genes that are up- or down-regulated in
tissues or cells involved in allergic disease, something that
might contribute to the identification of new pathological
mechanisms or therapeutic targets [17]. However, all reg-
ulatory mechanisms are not operated at the transcrip-
tional level. Hence, one of the disadvantages with DNA
microarray technology is that the detected mRNA levels
not always correlate with the actual protein levels in the
sample. 2-DE together with MS-analysis is a powerful
method to profile the protein expression in different sam-
ples. Two previous studies have used this methodology to
analyse proteins in lavage fluids from the upper airways
[6,14]. The present data now demonstrate that this
approach also can be used to compare healthy and patho-
logical samples in order to get an overview of which pro-
teins that can be of importance for the development of
allergic diseases.
Most of the 21 proteins identified in the present study cor-
relate well with proteins found in NLF from normal,
healthy individuals in previous studies [5,6,14]. However,
6 of the proteins (psoriasin, galectin-3, alpha enolase,
intersectin-2, Wnt-2B and hypothetical protein
MGC33648) have not previously been described in NLF.
Psoriasin, also called S100A7, belongs to the S100 protein
family and like other members in this family (for example
calgranulin B) it has calcium-binding properties. It was
first identified in psoriatic skin [18] where it is highly up-
regulated. Psoriasin is thought to be involved in inflam-
mation since it is a potent chemotactic factor for CD4+ T
lymphocytes and neutrophils [19]. Galectin-3 belongs to
a family of β-galactoside-binding animal lectins [20]. It is
54 Hemopexin P02790 51.7 6.5
55 Hemopexin P02790 51.7 6.5
56 Hemopexin P02790 51.7 6.5
57 Ig gamma 2 chain c region P01859 35.9 7.7
58 Wnt-2B protein
(splice isoform 1)
Q93097-1 43.8 9.3
59 Fibrinogen beta chain P02675 55.9 8.5
60 Hypothetical protein 
MGC33648
IPI00168581 34.2 9.0
61 Actin, cytoplasmic 1 or 2 P60709 41.7 5.3
Proteins in bold are newly identified in NLF.
Table 1: Identified proteins in nasal lavage fluid from allergic and non-allergic individuals. (Continued)
Western blot analysis of NLF from healthy non-allergic indi- viduals Figure 2
Western blot analysis of NLF from healthy non-allergic indi-
viduals. (1) Psoriasin, (2) Wnt-2B, (3) Galectin-3, (4) Enolase.Respiratory Research 2005, 6:118 http://respiratory-research.com/content/6/1/118
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expressed in mast cells, monocytes/macrophages, neu-
trophils and eosinophils. Although galectin-3 lacks signal
peptide, it can be secreted [21] and it functions as chemo-
tactic factor for monocytes and macrophages [22]. Galec-
tin-3 also has the ability to bind Ig-E and increased mRNA
levels for galectin-3 have been found in neutrophils
derived from the blood of allergic patients [23]. Alpha
enolase is a ubiquitous multifunctional enzyme involved
in many different processes [24]. It has been reported as
an important allergen in inhalant allergies to fungi [25]
and specific IgE antibodies have been found in patients
allergic to fungi [26], all corroborating the notion that
alpha enolase might play a role in allergic reactions. One
spot was identified as splice isoform 2 of intersectin-2, a
cytoplasmic protein involved in endocytosis [27]. The
spot identified is probably a degradation product of inter-
sectin-2 since it is present at a much lower MW than the
theoretical value. Wnt-2B is a developmental protein that
might play a role as hematopoietic growth factor [28].
The role of these newly identified proteins in allergic rhin-
itis is not known and they all render further investigation.
However, special attention might be drawn to the two dif-
ferent forms of psoriasin [29] found to be down-regulated
during allergic rhinitis in the present study. Since allergic
rhinitis is an inflammatory disease and psoriasin is a
chemotactic factor for inflammatory cells one could have
expected the opposite. One explanation for this reversed
condition is that psoriasin in addition to its chemotactic
properties has an other not yet discovered role in the
inflammation process. In this context, it is also essential to
recognize that inflammation is normally a self-resolving
process with the existence of both positive and negative
regulators that ultimately allow complete resolution and
homeostasis. In the absence of resolution and clearance or
in the event of a dampened healing response, persistent
inflammation can arise in the form of tissue damage as
associated with chronic disease. Thus, the down-regula-
tion of psoriasin during the allergic inflammation could
be of importance for the natural resolution of the disease.
Previous findings [23] have suggested that galectin-3 is
involved in the inflammatory reaction seen in allergic
patients. However, in the present study no differences in
the galectin-3 content were seen when material from
allergic and non-allergic individuals were compared.
Alpha enolase was identified in two spots but any quanti-
tative difference between allergic and non-allergic individ-
uals could not be detected. In contrast, splice isoform 1 of
Wnt-2B was found to be up-regulated (2.5-fold) among
allergic individuals. Such an increase of the Wnt-2B secre-
tion might be related to the increased growth and matura-
tion stimulation of eosinophils and neutrophils often
seen during the allergic inflammation.
In addition to the novel NLF proteins psoriasin and Wnt-
2B, a group of other proteins were also found to be differ-
ently expressed during the allergic inflammation. There
was a 2.0-fold decrease of one form of prolactin-inducible
protein (PIP) in allergic individuals. PIP is expressed in
exocrine organs like sweat, salivary and lacrimal glands
[30]. The functions of PIP is not completely known but it
has CD4-binding properties and is a strong inhibitor of T
lymphocyte apoptosis [31]. A down-regulation of PIP
might therefore be associated with an increased apoptosis
of T lymphocytes, something that might contribute to a
Table 2: Proteins differently expressed in allergic and non-allergic individuals.
Protein No. Non-allergica Allergica Fold changes
Psoriasin 40 1831 ± 425 543 ± 110* -3.4
Psoriasin 41 7410 ± 1675 3689 ± 650* -2.0
Prolactin-inducible protein 29 2322 ± 491 1130 ± 194* -2.0
Transthyretin 38 1182 ± 177 1902 ± 286* 1.6
Ig gamma 2 chain c region 57 3493 ± 590 7349 ± 1137* 2.1
Wnt-2B protein (splice 
isoform 1)
58 3360 ± 668 8405 ± 1761* 2.5
Albumin fragment 6 803 ± 210 1580 ± 258* 2.0
Albumin fragment 11 363 ± 83 957 ± 247* 2.6
Albumin fragment 15 386 ± 99 606 ± 116* 2.4
Albumin fragment 17 514 ± 115 927 ± 86* 1.8
Albumin fragment 21 407 ± 74 1008 ± 183* 2.5
Albumin fragment 23 139 ± 50 324 ± 72* 2.3
Albumin fragment 20 2135 ± 374 3991 ± 638* 1.9
Albumin fragment 4 219 ± 54 500 ± 92* 2.3
a The amount of protein is expressed as mean %VOL (ppm) ± SEM.
* p < 0.05Respiratory Research 2005, 6:118 http://respiratory-research.com/content/6/1/118
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limitation of the inflammatory process. The theoretical pI
for PIP is 8.3 but it was detected in the gel at a pI around
4–5. Without its signal peptide the theoretical pI decreases
to 5.4 which is closer to our observation. Transthyretin,
also called prealbumin, is a plasma protein involved in
the transport of thyroxine and retinol [32]. The small up-
regulation of transthyretin detected in allergic individuals
(1.6-fold) is probably due to the increased plasma exuda-
tion seen in allergic rhinitis [2].
Several of the spots were identified as the same protein.
Hence, many proteins are present in different forms. The
different forms may result from post-translational modifi-
cations like phosphorylation, glycosylation, acetylation or
degradation of the proteins. All spots identified as albu-
min are probably different forms and fragments of
albumin and since albumin is highly abundant in plasma
this high amount of degradation products in NLF is
expected. It is not surprising that a few of these fragments
were up-regulated in allergic individuals since this only
confirms previous findings that the secretion of albumin
is increased in allergic individuals. Ig gamma 2 chain c
region was also found to be up-regulated in allergic indi-
viduals which also confirms previous findings [33].
Conclusion
2-DE in combination with MS-analysis appears to be a
powerful method to profile the protein expression and
compare healthy samples with pathological samples. In
this study both previously identified and newly identified
proteins were detected in NLF using this method. Some of
these proteins, like psoriasin, Wnt-2B and PIP were found
to be differently expressed in allergic and non-allergic
individuals. Further investigations are needed to explain
the pathological significance of these proteins. It is possi-
ble that some of them can be defined as new therapeutic
targets or diagnostic markers for allergic diseases.
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Expression analysis of psoriasin with western blot Figure 3
Expression analysis of psoriasin with western blot. A: Western blot analysis of NLF from three healthy non-allergic individuals 
(1–3) and three allergic individuals (4–6) demonstrating the levels of psoriasin. 1 µg of total protein was loaded in each lane. B: 
Quantitative analysis of western blot with ImageQuant (Molecular Dynamics, USA). Each data point represents the mean ± 
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